BXI Bioexx Specialty Proteins Ltd Com Npv

Bio-Extraction Inc. (TSX VENTURE:BXI)("BioExx" or "the Company") is pleased to
announce that it has filed a significant new patent application allowing for the
production of Protein Concentrates (up to 70% purity) from oilseed meal produced
in conventional, higher-temperature, processing facilities. While this
technology would not be used in the specialty low-temperature processing
facilities to be constructed and operated by BioExx, this does represent an
opportunity for BioExx to leverage its intellectual property through licensees
to rather simply and significantly increase the value of the meal produced in
existing conventional facilities. This value increase is enabled by the ability
to process conventional meal, which is primarily sold as lower value animal
feed, to produce Protein Concentrates which may sell for three to five times the
price of meal.


The initial licensing focus of the Company will be on canola and rapeseed meal
markets. With 2007/08 crop year global production of conventional canola and
rapeseed meal at 27.7 million metric tonnes (source: USDA), this represents a
potentially significant and complementary new source of passive licensing
revenue for BioExx over the medium to long term, in addition to the revenues
from its core business of owning and operating high-value protein isolate
production facilities.


Due to the fundamental limitations created by high temperature canola and
rapeseed processing, the Protein Concentrates produced by this new method would
be suitable only for use in specialty feed markets, and not suitable for the
human-food Protein Isolate markets which are the core business and key focus of
BioExx. It is not possible with this technology to produce the higher-value
BioExx Protein Isolates, which are a completely different product, with much
higher purity, solubility, and a significantly different amino acid profile.
Although this new patent-pending process was created as an offshoot of the
BioExx development work in that area, when these novel methods were modified for
extension to standard toasted meal as an input, a high quality Protein
Concentrate was created. The product shows a strong nutritional profile,
suitable for specialty feed applications, with low anti-nutritional factors and
a mix of soluble and insoluble protein.


BioExx believes that the new process technology may be made available as a
relatively simple retrofit onto the back end of conventional canola processing
facilities, and with a capital and operating cost profile that would drive an
attractive return on investment for licensees. Without compromising its efforts
on the primary business of constructing and operating additional and larger
facilities to produce high-value protein isolates, BioExx plans to spend the
next year working confidentially with selected licensees to fully develop this
unique new technology, with a targeted initial commercialization within the next
24 months. Licensing in this manner is also intended to enable deployment and
revenue generation without any significant additional capital expenditure by
BioExx.


"While we are very excited about this new development, we have no intention of
letting it impair our very strong progress or our timetable for protein isolate
production in Saskatoon. Given that our team was able to complete this project
in less than six months and at minimal cost, we see it as indicative of the
broad reach of potential advancements that can and will be achieved through the
application of our unique and growing portfolio of intellectual property," said
BioExx CEO, Chris Carl. "Our team remains firmly committed to and highly
confident in the successful commercialization of our protein isolate production
in Saskatoon in mid Q1 2010, and all work in that regard is proceeding well and
according to plan."


Patent Portfolio Update

BioExx also recently filed two additional patent applications that are directly
related to the specialty proteins to be produced at BioExx facilities, bringing
the total number of patents issued and pending to ten.


The increasingly broad patent portfolio that BioExx has developed protects its
very unique and proprietary processes and products. The scope of this portfolio
now covers:




--  Protection of scalable, economic low temperature extraction methods 
--  Protection of unique solvent combinations to effect such extractions 
--  Protection of unique solvent separation and recovery methods 
--  Protection of unique methods of producing protein concentrates, protein
    isolates and hydrolyzed protein extracts from oilseeds 
--  Protection of the unique products resulting from the foregoing processes



The BioExx protein patent claims also cover rapeseed, mustard seed, soy, and
flax and hence are not limited to canola protein.


The BioExx process that is being deployed for commercial protein isolate
production does not use high temperatures or process additives that cannot be
fully removed from the end products, and specifically does not use salt
solutions, in any form, at any stage in the process. The processes and products
that BioExx has developed have undergone extensive scientific and legal review,
including substantial product testing, to confirm their unique properties and
assessment of freedom to operate in the marketplace.


About Bio-Extraction Inc.

Headquartered in Toronto, Canada, BioExx is a leading technology and industrial
processing company focused on the extraction of oil and high-value proteins from
oilseeds for the global food, beverage, and nutrition markets. BioExx's patented
technology allows for the use of significantly lower temperatures than
conventional methods in extracting the active ingredients and oils from
oilseeds, resulting in higher yields and higher-quality meal, oils and proteins.
BioExx's low energy requirements, environmentally sound process, and high-yield
production have the potential to make a valuable contribution to global food and
protein markets. BioExx operates a commercial scale facility in Saskatoon,
Saskatchewan, and has a mission to construct additional and larger processing
facilities on a global basis. To find out more about Bio-Extraction Inc. (TSX
VENTURE:BXI), please visit www.bioexx.com.


"The statements made in this press release include forward-looking statements
that involve a number of risks and uncertainties. These statements relate to
future events or future performance and reflect management's current
expectations and assumptions. A number of factors could cause actual events,
performance or results to differ materially from the events, performance and
results discussed in the forward-looking statements, such as the economy,
generally, competition in its target markets, the demand for BioExx's products,
the availability of funding, the efficacy of its technology, and the anticipated
costs of BioExx's plant construction and operation. These forward-looking
statements are made as of the date hereof and BioExx does not assume any
obligation to update or revise them to reflect new events or circumstances.
Actual events or results could differ materially from BioExx's expectations and
projections."

Bioexx Specialty Proteins Ltd Com Npv (TSXV:BXI)
Historical Stock Chart
From May 2024 to Jun 2024

Bioexx Specialty Proteins Ltd Com Npv (TSXV:BXI)
Historical Stock Chart
From Jun 2023 to Jun 2024